Posts in tag

cardiovascular


More work needs to be done to examine the real world effects of empagliflozin, new research finds Examining data from over 60,000 patients with type 2 diabetes, researchers from the …

Debbie Rigby takes a look at the latest in research news Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL …

Debbie Rigby rounds up the latest in research news Benzodiazepines, Z-drugs and the risk of hip fracture There is strong evidence that both BNZ and Z-drugs are associated with an …

Giving over-65s a statin to help prevent heart attack and death may not be useful, new research suggests—but one expert disagrees A new study published by JAMA Internal Medicine analysed …

Australians are underestimating the amount of salt they eat by at least a third, a new study has revealed The diets of more than 400 people were examined by The …

Louis Roller examines the ways in which pharmacists can help prevent and manage hypertension Hypertension, also known as high blood pressure, is a long term medical condition in which the blood pressure in the arteries is persistently elevated. …

People who know they are being given statins are more likely to report side effects than those who don’t know they’re taking them, a new study has found Published in …

Pharmacists should be expected to advise on how medicines and lifestyle impact heart health, writes Louis Roller Cardiovascular disease continues to have a major effect on the health of Australians …

Debbie Rigby rounds up the latest in research news Faecal Microbiota Transplantation in Clostridium difficile Infection: Evidence and Indications Faecal microbiota transplantation aims to rapidly restore the normal diverse colonic …

Debbie Rigby looks at the latest in research news Dapagliflozin: potential beneficial effects in the prevention and treatment of renal and cardiovascular complications in patients with type 2 diabetes This …

Painkillers like ibuprofen can increase the risk of heart disease and should be restricted Michael Stokes, University of Adelaide and Peter Psaltis, South Australian Health & Medical Research Institute Medications …

“Such was the pro-pharmacy headline greeting me this morning from last night’s Australian Doctor, reporting on a Danish study in European Heart Journal.   NSAIDs should not be available for open …